These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32482952)

  • 1. Impact of Pain, Opioids, and the Mu-opioid Receptor on Progression and Survival in Patients With Newly Diagnosed Stage IV Pancreatic Cancer.
    Steele GL; Dudek AZ; Gilmore GE; Richter SA; Olson DA; Eklund JP; Zylla DM
    Am J Clin Oncol; 2020 Aug; 43(8):591-597. PubMed ID: 32482952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer.
    Zylla D; Gourley BL; Vang D; Jackson S; Boatman S; Lindgren B; Kuskowski MA; Le C; Gupta K; Gupta P
    Cancer; 2013 Dec; 119(23):4103-10. PubMed ID: 24104703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of opioid use on health care utilization and survival in patients with newly diagnosed stage IV malignancies.
    Zylla D; Steele G; Shapiro A; Richter S; Gupta P
    Support Care Cancer; 2018 Jul; 26(7):2259-2266. PubMed ID: 29396593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.
    Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA
    Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and morphological measurements of subcutaneous and visceral fat and their relationship with disease stage and overall survival in newly diagnosed pancreatic adenocarcinoma : Metabolic and morphological fat measurements in pancreatic adenocarcinoma.
    Van de Wiele C; Van Vlaenderen M; D'Hulst L; Delcourt A; Copin D; De Spiegeleer B; Maes A
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):110-116. PubMed ID: 27730330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioids and cancer prognosis: A summary of the clinical evidence.
    Ramirez MF; Gorur A; Cata JP
    Neurosci Lett; 2021 Feb; 746():135661. PubMed ID: 33482308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer.
    Fong D; Spizzo G; Mitterer M; Seeber A; Steurer M; Gastl G; Brosch I; Moser P
    Ann Surg Oncol; 2012 Dec; 19(13):4330-6. PubMed ID: 22549289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OPRM1 Methylation Contributes to Opioid Tolerance in Cancer Patients.
    Viet CT; Dang D; Aouizerat BE; Miaskowski C; Ye Y; Viet DT; Ono K; Schmidt BL
    J Pain; 2017 Sep; 18(9):1046-1059. PubMed ID: 28456745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Intraoperative Opioid Use on Recurrence-Free and Overall Survival in Patients With Esophageal Adenocarcinoma and Squamous Cell Carcinoma.
    Du KN; Feng L; Newhouse A; Mehta J; Lasala J; Mena GE; Hofstetter WL; Cata JP
    Anesth Analg; 2018 Jul; 127(1):210-216. PubMed ID: 29757780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer.
    Yang SH; Guo JC; Yeh KH; Tien YW; Cheng AL; Kuo SH
    J Gastroenterol Hepatol; 2016 Dec; 31(12):2004-2012. PubMed ID: 27059987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Association of Serum Opioid Levels and Clinical Outcomes in Patients With Cancer Pain Treated With Intrathecal Opioid Therapy.
    Brogan SE; Sindt JE; Jackman CM; White J; Wilding V; Okifuji A
    Anesth Analg; 2020 Apr; 130(4):1035-1044. PubMed ID: 31206429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].
    Soriano-Izquierdo A; Adet AC; Gallego R; Miquel R; Castells A; Pellisé M; Nadal C; López-Boado MA; Piqué JM; Gascón P; Conill C; Bombí A; Fernández-Cruz L; Maurel J; Navarro S
    Med Clin (Barc); 2009 Feb; 132(5):163-71. PubMed ID: 19211081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine as a treatment of cancer-induced pain-is it safe? A review of in vivo studies and mechanisms.
    Brinkman D; Wang JH; Redmond HP
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Nov; 391(11):1169-1178. PubMed ID: 30232510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival analysis of veteran patients with pancreatic cancer.
    Kim D; Zhu H; Nassri A; Mokdad A; Kukreja S; Polanco P; Huerta S; Ramzan Z
    J Dig Dis; 2016 Jun; 17(6):399-407. PubMed ID: 27235863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Opioid Use and Survival Time in Patients With Unresectable Pancreatic Cancer: 10 Years of Clinical Experience.
    Oh TK; Do SH; Yoon YS; Song IA
    Pancreas; 2018 Aug; 47(7):837-842. PubMed ID: 29939907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial.
    Wong GY; Schroeder DR; Carns PE; Wilson JL; Martin DP; Kinney MO; Mantilla CB; Warner DO
    JAMA; 2004 Mar; 291(9):1092-9. PubMed ID: 14996778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnane X Receptor Expression in Human Pancreatic Adenocarcinoma: Associations With Clinicopathologic Parameters, Tumor Proliferative Capacity, Patients' Survival, and Retinoid X Receptor Expression.
    Koutsounas I; Giaginis C; Alexandrou P; Zizi-Serbetzoglou A; Patsouris E; Kouraklis G; Theocharis S
    Pancreas; 2015 Oct; 44(7):1134-40. PubMed ID: 26355550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic opioid exposure on guinea pig mu opioid receptor in Chinese hamster ovary cells: comparison with human and rat receptor.
    Wallisch M; Nelson CS; Mulvaney JM; Hernandez HS; Smith SA; Olsen GD
    Biochem Pharmacol; 2007 Jun; 73(11):1818-28. PubMed ID: 17343833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Perioperative Opioids on Cancer-Relevant Circulating Parameters: Mu Opioid Receptor and Toll-Like Receptor 4 Activation Potential, and Proteolytic Profile.
    Xie N; Matigian N; Vithanage T; Gregory K; Nassar ZD; Cabot PJ; Shaw PN; Kirkpatrick CMJ; Cao KL; Sturgess D; Parat MO
    Clin Cancer Res; 2018 May; 24(10):2319-2327. PubMed ID: 29511031
    [No Abstract]   [Full Text] [Related]  

  • 20. Morphine Suppresses Lung Cancer Cell Proliferation Through the Interaction with Opioid Growth Factor Receptor: An In Vitro and Human Lung Tissue Study.
    Kim JY; Ahn HJ; Kim JK; Kim J; Lee SH; Chae HB
    Anesth Analg; 2016 Dec; 123(6):1429-1436. PubMed ID: 27167686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.